Clinical Trials of an Innovative, First-in-Class Oral Therapy for the Treatment of a Broad Range of Women With HR+/HER2- Metastatic Breast Cancer
Pfizer Cordially Invites You to Attend: An Informational Program: Clinical Trials of an Innovative, First-in-Class Oral Therapy for the Treatment of a Broad Range of Women With HR+/HER2- Metastatic Breast Cancer Featuring; JOHN PARK MD University of California San Francisco Hosted by Joyce Lew
|
|